OSANG Healthcare pioneers FDA’s first dual virus detection kit for the American market.

OSANG Healthcare’s new COVID-19 and influenza (flu) combo kit received approval from the U.S. Food and Drug Administration (FDA), clearing the way for its sale in the United States. This diagnostic device can simultaneously determine the infection status of COVID-19 and influenza types A and B.

1) article

https://biz.chosun.com/en/en-science/2025/01/14/NYH5QOB7KBHB7NX6YALKJPCAUU/

2) FDA Site
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K243262